Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 29, 1999

View Archived Issues

Published Data Show Infliximab Also Helps Stop Joint Damage

CAT Partners With Searle In Deal Worth Up To US$150M

MorphoSys, Bayer Form Broad Collaboration Around Antibodies

UK Genomics Initiative Involves Collection Of DNA For Database

Paladin Acquires Neurocrine Program To Broaden Pipeline

Juvantia Pharma Enters Clinic With Anti-Parkinson's Candidate

Australian Researchers Discover Genes Linked To Obesity, Testes

Matrix Moves Right Into Clinic Following Recent Formation

Evotec Enters Agreement To Screen 10 Targets For Knoll

European Patent Board Affirms Patentability Of Plants, Animals

NicOx Begins Phase II Study Of Paget's Disease Candidate

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.